127 related articles for article (PubMed ID: 35690523)
21. Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation.
Zhuang BW; Li W; Qiao B; Zhang N; Lin MX; Wang W; Kuang M; Lu MD; Xie XY; Xie XH
Int J Hyperthermia; 2022; 39(1):1143-1151. PubMed ID: 36039777
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation.
Chen TM; Lin CC; Huang PT; Wen CF
J Gastroenterol Hepatol; 2012 Mar; 27(3):553-61. PubMed ID: 21913982
[TBL] [Abstract][Full Text] [Related]
23. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Chu MO; Shen CH; Chang TS; Xu HW; Yen CW; Lu SN; Hung CH
Sci Rep; 2018 Nov; 8(1):16611. PubMed ID: 30413724
[TBL] [Abstract][Full Text] [Related]
26. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
27. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
Yang Y; Chen Y; Ye F; Cao X; Xin Y; Wang Y; Lei Y; Li X; Feng D; Zhou X; Fan Q
Eur Radiol; 2021 May; 31(5):3053-3064. PubMed ID: 33175203
[TBL] [Abstract][Full Text] [Related]
28. Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation.
Lee S; Kang TW; Song KD; Lee MW; Rhim H; Lim HK; Kim SY; Sinn DH; Kim JM; Kim K; Ha SY
Ann Surg; 2021 Mar; 273(3):564-571. PubMed ID: 31058694
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablation.
Maruyama H; Takahashi M; Shimada T; Sekimoto T; Kamesaki H; Kanai F; Yokosuka O
AJR Am J Roentgenol; 2013 Mar; 200(3):570-7. PubMed ID: 23436846
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
Shiina S; Tateishi R; Arano T; Uchino K; Enooku K; Nakagawa H; Asaoka Y; Sato T; Masuzaki R; Kondo Y; Goto T; Yoshida H; Omata M; Koike K
Am J Gastroenterol; 2012 Apr; 107(4):569-77; quiz 578. PubMed ID: 22158026
[TBL] [Abstract][Full Text] [Related]
31. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
32. [Study of the risk factors for recurrence of early and late stage hepatocellular carcinoma after hepatic artery embolization combined with radiofrequency ablation therapy].
Sun Y; Zhang HH; Zheng JS; Zhang YH
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):1001-1005. PubMed ID: 34814396
[No Abstract] [Full Text] [Related]
33. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
[TBL] [Abstract][Full Text] [Related]
34. Radiofrequency ablation of hepatocellular carcinoma: CT texture analysis of the ablated area to predict local recurrence.
Beleù A; Autelitano D; Geraci L; Aluffi G; Cardobi N; De Robertis R; Martone E; Conci S; Ruzzenente A; D'Onofrio M
Eur J Radiol; 2022 May; 150():110250. PubMed ID: 35367776
[TBL] [Abstract][Full Text] [Related]
35. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
Wang Y; Liao J; Qi W; Xie L; Li Y
Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
[TBL] [Abstract][Full Text] [Related]
36. Pre-radiofrequency ablation MRI imaging features predict the local tumor progression in hepatocellular carcinoma.
Hu Z; Yu N; Wang H; Li S; Yan J; Zhang G
Medicine (Baltimore); 2020 Dec; 99(52):e23924. PubMed ID: 33350797
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for recurrence beyond Milan criteria after radiofrequency ablation in transplantable small hepatocellular carcinoma.
Chu W; Li P; Wu X; Zhang P; Zhou H; Niu B
Rev Esp Enferm Dig; 2022 Oct; 114(10):580-585. PubMed ID: 35042367
[TBL] [Abstract][Full Text] [Related]
38. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study.
Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC
Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354
[TBL] [Abstract][Full Text] [Related]
39. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of combined preoperative-postoperative neutrophil-to-lymphocyte ratio in predicting hepatocellular carcinoma prognosis after radiofrequency ablation.
Ni Z; Wu B; Liu Z; Wang Q; Han X; Cheng W; Guo C
Br J Radiol; 2023 Apr; 96(1145):20220887. PubMed ID: 36715151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
